We are investigating a new drug for patients with inoperable advanced breast cancer who have progressed after previous treatment. The study aims to understand its safety and effectiveness, both alone and in combination with other therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
HER2-positive and HER2-low breast cancer refers to types of breast cancer characterized by the presence of the HER2 protein. Patients with HER2-positive tumors have high levels of this protein, while those with HER2-low tumors have lower levels. This condition often requires specific treatments and monitoring.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.